WS9-11709-38269
3 vaccinations
1 coded response
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 275 / NC
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-03-31
- 2021-04-02
- 2021-04-03
- 2021-04-10
-
2021-04-17
Dose 2 — Pfizer-BioNTech
- 2021-04-17
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-21
- 2021-04-26
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-07-19
- 2021-10-18
-
2021-11-21
Dose 3 — Pfizer-BioNTech
-
2022-04-19
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-21
- 2022-05-24
- 2022-11-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-19 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release